nach oben

Erschienen in:

12.11.2018 | Original Article

Microbiome and its relation to gestational diabetes

verfasst von: Ramon V. Cortez, Carla R. Taddei, Luiz G. Sparvoli, Ana G. S. Ângelo, Marina Padilha, Rosiane Mattar, Silvia Daher

Erschienen in: Endocrine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Gestational diabetes mellitus (GDM), the major endocrine pathology in pregnancy, has been associated with the development of an intense inflammatory process and increased insulin resistance. The maternal microbiota is involved in several metabolic functions; however, its role in GDM physiopathology remains unclear. The aim of this study was to assess the composition of the microbiota at different sites and evaluate its relationship with the occurrence of GDM.

Methods

This cross-sectional study recruited women in the third trimester of gestation with and without GDM. Oral, vaginal, and stool samples were evaluated using next-generation sequencing. We included 68 participants: 26 with and 42 without GDM.

Results

The analysis of the oral microbiome did not show significant differences in phyla and genus among the studied groups. In contrast, GDM patients presented a specific vaginal and intestinal microbiome composition, which was less diverse than those found in the control group, showing genera related to dysbiosis.

Conclusions

Our findings suggest that changes in the composition of the vaginal and intestinal microbiome might be involved in the development of GDM. The follow-up of these patients in order to evaluate vaginal and intestinal samples after delivery may contribute to understanding the development of metabolic disease in women with previous GDM.

Nur mit Berechtigung zugänglich

World Health Organization, Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy (World Health Organization, Geneva, 2013)

O. Verier-Mine, Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Lit. Rev. Diabetes Metab. 36, 595–616 (2010)CrossRef

G. Di Cianni, R. Miccoli, L. Volpe, C. Lencioni, S. Del Prato, Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab. Res. Rev. 19, 259–270 (2003)CrossRefPubMed

D. Zhang, Y. Huang, D. Ye, Intestinal dysbiosis: an emerging cause of pregnancy complications? Med. Hypotheses 84, 233–236 (2015)

P.D. Cani, L. Geurts, S. Matamoros, H. Plovier, T. Duparc, Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab. 40, 246–257 (2014)CrossRefPubMed

W.G. Wade, The oral microbiome in health and disease. Pharmacol. Res. 69, 137–143 (2013)CrossRefPubMed

N. Makiura, M. Ojima, Y. Kou, N. Furuta, N. Okahashi, S. Shizukuishi, A. Amano, Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Oral. Microbiol. Immunol. 23, 348–351 (2008)CrossRefPubMed

K. Aagaard, K. Riehle, J. Ma, N. Segata, T.A. Mistretta, C. Coarfa, S. Raza, S. Rosenbaum, I. Van den Veyver, A. Milosavljevic, D. Gevers, C. Huttenhower, J. Petrosino, J. Versalovic, Metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE 7, e36466 (2012)CrossRefPubMedPubMedCentral

R. Romero, S.S. Hassan, P. Gajer, A.L. Tarca, D.W. Fadrosh, L. Nikita, M. Galuppi, R.F. Lamont, P. Chaemsaithong, J. Miranda, T. Chaiworapongsa, J. Ravel, The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2, 4 (2014)CrossRefPubMedPubMedCentral

10.

K. Hyvärinen, A. Salminen, V. Salomaa, P.J. Pussinen, Systemic exposure to a common periodontal pathogen and missing teeth are associated with metabolic syndrome. Acta Diabetol. 52, 179–182 (2015)CrossRefPubMed

11.

M. Kilian, I.L.C. Chapple, M. Hannig, P.D. Marsh, V. Meuric, A.M.L. Pedersen, M.S. Tonetti, W.G. Wade, E. Zaura, The oral microbiome—an update for oral healthcare professionals. Br. Dent. J. 221, 657–666 (2016)CrossRefPubMed

12.

D. Nasioudis, L.J. Forney, G.M. Schneider, K. Gliniewicz, M. France, A. Boester, M. Sawai, J. Scholl, S.S. Witkin, Influence of pregnancy history on the vaginal microbiome of pregnant women in their first trimester. Sci. Rep. 7, 10201 (2017)CrossRefPubMedPubMedCentral

13.

C.R. Taddei, R.V. Cortez, R. Mattar, M.R. Torloni, S. Daher, Microbiome in normal and pathological pregnancies: a literature overview. Am. J. Reprod. Immunol. 80, e12993 (2018)CrossRefPubMed

14.

J. Wang, J. Zheng, W. Shi, N. Du, X. Xu, Y. Zhang, P. Ji, F. Zhang, Z. Jia, Y. Wang, Z. Zheng, H. Zhang, F. Zhao, Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus. Gut 67, 1614–1625 (2018)CrossRefPubMed

15.

J.J. Kozich, S.L. Westcott, N.T. Baxter, S.K. Highlander, P.D. Schloss, Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112–5120 (2013)CrossRefPubMedPubMedCentral

16.

J.G. Caporaso, J. Kuczynski, J. Stombaugh, K. Bittinger, F.D. Bushman, E.K. Costello, N. Fierer, A.G. Peña, J.K. Goodrich, J.I. Gordon, G.A. Huttley, S.T. Kelley, D. Knights, J.E. Koenig, R.E. Ley, C.A. Lozupone, D. McDonald, B.D. Muegge, M. Pirrung, J. Reeder, J.R. Sevinsky, P.J. Turnbaugh, W.A. Walters, J. Widmann, T. Yatsunenko, J. Zaneveld, R. Knight, QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010)CrossRefPubMedPubMedCentral

17.

R.C. Edgar, B.J. Haas, J.C. Clemente, C. Quince, R. Knight, UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194–2200 (2011)CrossRefPubMedPubMedCentral

18.

C. Quast, E. Pruesse, P. Yilmaz, J. Gerken, T. Schweer, P. Yarza, J. Peplies, F.O. Glockner, The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013)CrossRefPubMed

19.

Chao, A. Species richness estimation. ed. by N Balakrishnan, C. B. Read, and B. Vidakovic. In Encyclopedia of Statistical Sciences (Wiley, New York, 2005) pp. 7909–16

20.

C.E. Shannon, The mathematical theory of communication. Md. Comput. 14, 306–317 (1963)

21.

V.S. Pylro, L.F.W. Roesch, D.K. Morais, I.M. Clark, P.R. Hirsch, M.R. Tótola, Data analysis for 16S microbial profiling from different benchtop sequencing platforms. J. Microbiol. Methods 107, 30–37 (2014)CrossRefPubMed

22.

C. Lozupone, R. Knight, UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228–8235 (2005)CrossRefPubMedPubMedCentral

23.

J.A. Navas-Molina, J.M. Peralta-Sánchez, A. González, P.J. McMurdie, Y. Vázquez-Baeza, Z. Xu, L.K. Ursell, C. Lauber, H. Zhou, S.J. Song, J. Huntley, G.L. Ackermann, D. Berg-Lyons, S. Holmes, J.G. Caporaso, R. Knight, Advancing our understanding of the human microbiome using QIIME. Methods Enzymol. 531, 371–444 (2013)CrossRefPubMedPubMedCentral

24.

A.J. Oksanen, F.G. Blanchet, M. Friendly, R. Kindt, P. Legendre, D. Mcglinn, P.R. Minchin, R.B.O. Hara, G.L. Simpson, P. Solymos, M.H.H. Stevens, E. Szoecs, Vegan: community ecology package. R. Package Version 2, 2–0 (2014. http://CRAN.Rproject.org/package=vegan

25.

O. Koren, J.K. Goodrich, T.C. Cullender, A. Spor, K. Laitinen, H.K. Bäckhed, A. Gonzalez, J.J. Werner, L.T. Angenent, R. Knight, F. Bäckhed, E. Isolauri, S. Salminen, R.E. Ley, Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150, 470–480 (2012)CrossRefPubMedPubMedCentral

26.

D.B. DiGiulio, B.J. Callahan, P.J. McMurdie, E.K. Costello, D.J. Lyell, A. Robaczewska, C.L. Sun, D.S.A. Goltsman, R.J. Wong, G. Shaw, D.K. Stevenson, S.P. Holmes, D.A. Relman, Temporal and spatial variation of the human microbiota during pregnancy. Proc. Natl Acad. Sci. USA 112, 11060–11065 (2015)CrossRefPubMedPubMedCentral

27.

M. Fugmann, M. Breier, M. Rottenkolber, F. Banning, U. Ferrari, V. Sacco, H. Grallert, K.G. Parhofer, J. Seissler, T. Clavel, A. Lechner, The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. Sci. Rep. 5, 13212 (2015)CrossRefPubMedPubMedCentral

28.

T. Jost, C. Lacroix, C. Braegger, C. Chassard, Stability of the maternal gut microbiota during late pregnancy and early lactation. Curr. Microbiol. 68, 419–427 (2014)CrossRefPubMed

29.

S.M. Nelson, P. Matthews, L. Poston, Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum. Reprod. Update 16, 255–275 (2010)CrossRefPubMed

30.

R.E. Ley, F. Backhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, J.I. Gordon, Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070–11075 (2005)CrossRefPubMedPubMedCentral

31.

M.K.W. Crusell, T.H. Hansen, T. Nielsen, K.H. Allin, M.C. Rühlemann, P. Damm, H. Vestergaard, C. Rørbye, N.R. Jørgensen, O.B. Christiansen, F.A. Heinsen, A. Franke, T. Hansen, J. Lauenborg, O. Pedersen, Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome 6, 89 (2018)CrossRefPubMedPubMedCentral

32.

M.C. Collado, E. Isolauri, K. Laitinen, S. Salminen, Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nutr. 88, 894–899 (2008)CrossRefPubMed

33.

A. Santacruz, M.C. Collado, L. García-Valdés, M.T. Segura, J.A. Martín-Lagos, T. Anjos, M. Martí-Romero, R.M. Lopez, J. Florido, C. Campoy, Y. Sanz, Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104, 83–92 (2010)CrossRefPubMed

34.

P.D. Cani, W.M. de Vos, Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8, 1765 (2017)CrossRefPubMedPubMedCentral

35.

P.D. Cani, Metabolism in 2013: the gut microbiota manages host metabolism. Nat. Rev. Endocrinol. 10, 74–76 (2014)CrossRefPubMed

36.

O.B. Christiansen, Reproductive immunology. Mol. Immunol. 55, 8–15 (2013)CrossRefPubMed

37.

M.C. Dao, A. Everard, J. Aron-Wisnewsky, N. Sokolovska, E. Prifti, E.O. Verger, B.D. Kayser, F. Levenez, J. Chilloux, L. Hoyles, M.E. Dumas, S.W. Rizkalla, J. Doré, P.D. Cani, K. Clément, S. Le Mouhaër, A. Cotillard, S.P. Kennedy, N. Pons, E. Le Chatelier, M. Almeida, B. Quinquis, N. Galleron, J.M. Batto, P. Renault, J.D. Zucker, S.D. Ehrlich, H. Blottière, M. Leclerc, C. Juste, T. De Wouters, P. Lepage, Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426–436 (2016)CrossRefPubMed

38.

Y.S. Kuang, J.H. Lu, S.H. Li, J.H. Li, M.Y. Yuan, J.R. He, N.N. Chen, W.Q. Xiao, S.Y. Shen, L. Qiu, Y.F. Wu, C.Y. Hu, Y.Y. Wu, W.D. Li, Q.Z. Chen, H.W. Deng, C.J. Papasian, H.M. Xia, X. Qiu, Connections between the human gut microbiome and gestational diabetes mellitus. Gigascience 6, 1–12 (2017)CrossRefPubMedPubMedCentral

39.

V. Lecomte, N.O. Kaakoush, C.A. Maloney, M. Raipuria, K.D. Huinao, H.M. Mitchell, M.J. Morris, Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS ONE 10, e0126931 (2015)CrossRefPubMedPubMedCentral

40.

H.M. Tun, S.L. Bridgman, R. Chari, C.J. Field, D.S. Guttman, A.B. Becker, P.J. Mandhane, S.E. Turvey, P. Subbarao, M.R. Sears, J.A. Scott, A.L. Kozyrskyj, Roles of birth mode and infant gut microbiota in intergenerational transmission of overweight and obesity from mother to offspring. JAMA Pediatr. 172, 368–377 (2018)CrossRefPubMedPubMedCentral

41.

J.A. Aas, B.J. Paster, L.N. Stokes, I. Olsen, F.E. Dewhirst, Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43, 5721–5732 (2005)CrossRefPubMedPubMedCentral

42.

Y.W. Han, X. Wang, Mobile microbiome. J. Dent. Res. 92, 485–491 (2013)CrossRefPubMedPubMedCentral

43.

J. Acuna, O. Cohavy, I. Solt, J. Reeder, M. Kim, I. Lebovics, B. Paster, R. Knight, S. Rotmensch, Preliminary observations on the microbial phylogeny of the oral, vaginal, and rectal microbiome in gestational diabetes and healthy pregnancies. Am. J. Obstet. Gynecol. 204, S109–S110 (2011)CrossRef

44.

R. Rampersaud, T.M. Randis, A.J. Ratner, Microbiota of the upper and lower genital tract. Semin. Fetal Neonatal Med. 17, 51–57 (2012)CrossRefPubMed

45.

A. Cotillard, S.P. Kennedy, L.C. Kong, E. Prifti, N. Pons, E. Le Chatelier, M. Almeida, B. Quinquis, F. Levenez, N. Galleron, S. Gougis, S. Rizkalla, J.M. Batto, P. Renault, J. Doré, J.D. Zucker, K. Clément, S.D. Ehrlich, S.D. Ehrlich, Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588 (2013)CrossRefPubMed

46.

S. Hasan, V. Aho, P. Pereira, L. Paulin, S.B. Koivusalo, P. Auvinen, J.G. Eriksson, Gut microbiome in gestational diabetes: a Cross-sectional study of mothers and offspring 5 years post-partum. Acta Obstet. Gynecol. Scand. 97, 38–46 (2018)CrossRefPubMed

Titel: Microbiome and its relation to gestational diabetes
verfasst von: Ramon V. Cortez
Carla R. Taddei
Luiz G. Sparvoli
Ana G. S. Ângelo
Marina Padilha
Rosiane Mattar
Silvia Daher
Publikationsdatum: 12.11.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1813-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Auricular calcification in a patient with traumatic brain injury and adrenal insufficiency: clinico-radiographic correlation with 3D cinematic rendering

Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys3]-GHRP-6

l-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia

Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk

BRAFV600E-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response